ArticleFrontiers in pediatrics2026
Case Report: Successful primary sutureless repair of common pulmonary vein atresia in a neonate.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Common pulmonary vein atresia (CPVA) is an extremely rare and lethal congenital heart defect characterized by the absence of a functional connection between the common pulmonary vein chamber (CPVC) and both the left atrium and systemic venous system. We report a case of a full-term female infant who successfully underwent primary sutureless repair. The patient developed acute respiratory distress syndrome (ARDS) with severe cyanosis and refractory hypoxemia 12 min after birth and underwent emergent surgery at 15 h of life. Intraoperative findings confirmed CPVA with bilateral superior pulmonary vein stenosis. Sutureless anastomosis was performed, leaving a 2.5 mm interatrial communication. Due to severe pulmonary hypertension and high-dose vasoactive requirements, venoarterial extracorporeal membrane oxygenation (VA-ECMO) support was established immediately. ECMO was weaned on postoperative day 6, the patient was extubated on day 10, and discharged on day 43. Two-month follow-up showed unobstructed pulmonary venous flow without evidence of anastomotic stenosis. To our knowledge, this is the first report of successful primary sutureless repair of this cardiac malformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.